Association of a Single-Nucleotide Variant rs11100494 of the <i>NPY5R</i> Gene with Antipsychotic-Induced Metabolic Disorders

Background: The usage of antipsychotics (APs) is the most robust and scientifically based approach in the treatment of schizophrenia spectrum disorders (SSDs). The efficiency of APs is based on a range of target receptors of the central nervous system (CNS): serotoninergic, dopaminergic, adrenergic,...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Vera S. Dobrodeeva, Natalia A. Shnayder, Maxim A. Novitsky, Azat R. Asadullin, Elena E. Vaiman, Marina M. Petrova, Oleg V. Limankin, Nikolay G. Neznanov, Natalia P. Garganeeva, Regina F. Nasyrova
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2022-01-01
Цуврал:	Pharmaceutics
Нөхцлүүд:	pharmacogenetics schizophrenia NPYR neuropeptide Y receptor antipsychotic-induced weight gain adverse drug reactions
Онлайн хандалт:	https://www.mdpi.com/1999-4923/14/2/222
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!